Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer

Neoadjuvant chemotherapy has practical and theoretical advantages over adjuvant chemotherapy strategy in breast cancer (BC) management. Moreover, metronomic delivery has a more favorable toxicity profile. The present study examined the feasibility of neoadjuvant metronomic chemotherapy in two cohort...

Full description

Bibliographic Details
Main Authors: V. Petry, D.M. Gagliato, A.I.C. Leal, R.J. Arai, E. Longo, F. Andrade, M.D. Ricci, J.R. Piato, R. Barroso-Sousa, P.M. Hoff, M.S. Mano
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2015-05-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000500479&lng=en&tlng=en